Chronic obstructive pulmonary disease (COPD) is one of the major causes of disability and
death. Maintenance use of inhaled bronchodilator (s) is the cornerstone of COPD …

Introduction: Current guidelines recommend the use of inhaled long-acting bronchodilators,
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …

Chronic obstructive pulmonary disease (COPD) is a chronic, inflammatory lung disease
characterized by airflow limitation that is not fully reversible. The pathological changes in …

Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Chronic obstructive pulmonary disease (COPD) is a devastating illness characterized by
airway and systemic inflammation, progressive airway obstruction and exacerbations. It is a …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Introduction As of today, there is still a need to determine which COPD patients may benefit
from ICS therapy, whether ICSs are useful in COPD patients without chronic bronchitis, and …

Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease
(COPD). Since inflammatory processes play a key role in the pathogenesis of the disease …

Inhaled corticosteroids (ICSs) belong to the armament for treatment of chronic obstructive
pulmonary disease (COPD) and as such, they are widely used in real life. This is a narrative …

The use of inhaled corticosteroids (ICSs) in long-term treatment of COPD has been a
debated topic for a long time. According to the evidence produced till now, ICSs are …